They don't know, nor do you. No need for dramatics, take a moment.
The paper is now conspicuously overdue. Hopefully it's not an indication of difficulties with any journal. The PD and FX trial starts are also taking far longer than expected, which is disappointing. Let's see what Sept brings. I'm pretty confident the AD MAA package can be delivered in early Q4, as Missling has recently projected.